Affiliations 

  • 1 Department of Pharmacy, COMSATS University Islamabad, Lahore Campus, Lahore, Pakistan
  • 2 Department of Clinical Sciences, Ajman University, Ajman, United Arab Emirates
  • 3 Department of Pharmacy, University of Sargodha, Sargodha, Pakistan
  • 4 School of Pharmaceutical Sciences, University of Science Malaysia, Pulau Pinang, Malaysia
  • 5 College of Pharmacy, South-Central University for Nationalities, Wuhan, China
Pathol Oncol Res, 2021;27:1609828.
PMID: 34588926 DOI: 10.3389/pore.2021.1609828

Abstract

A hormonal imbalance may disrupt the rigorously monitored cellular microenvironment by hampering the natural homeostatic mechanisms. The most common example of such hormonal glitch could be seen in obesity where the uprise in adipokine levels is in virtue of the expanding bulk of adipose tissue. Such aberrant endocrine signaling disrupts the regulation of cellular fate, rendering the cells to live in a tumor supportive microenvironment. Previously, it was believed that the adipokines support cancer proliferation and metastasis with no direct involvement in neoplastic transformations and tumorigenesis. However, the recent studies have reported discrete mechanisms that establish the direct involvement of adipokine signaling in tumorigenesis. Moreover, the individual adipokine profile of the patients has never been considered in the prognosis and staging of the disease. Hence, the present manuscript has focused on the reported extensive mechanisms that culminate the basis of poor prognosis and diminished survival rate in obese cancer patients.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.